New England Journal of Medicine publishes lupus drug trial paper authored by OMRF expert
The highest dose of the investigational drug iberdomide showed a reduction of lupus symptoms by the end of a 24-week, Phase 2 study. OMRF physician-scientist Joan Merrill, M.D., was the lead author of the paper.